Listed

GSK plc

An insider at 6 companies in coverage, as reported on Form 4. SEC CIK 1131399. Latest Form 4 filed Dec 15, 2025.

Share

Share this page

Story card, 1080 × 1920

Roles

As stated on the filings: the relationship to the company and any officer title.

CompanyRoleTransactionsFirstLatest
Wave Life Sciences, Inc.WVE10% owner32023-12-072025-12-11
Bicycle Therapeutics plcBCYC10% owner32020-07-142020-07-15
Progyny, Inc.PGNY10% owner32019-10-292020-05-20
Fulcrum Therapeutics, Inc.FULC10% owner22019-07-222019-07-22
Bicycle Therapeutics plcBCYCDirector, 10% owner52019-05-282019-05-28
Spero Therapeutics, Inc.SPRO10% owner102017-11-062018-07-17
CRISPR Therapeutics AGCRSP10% owner62016-10-182016-10-24

Transactions: 32

Every transaction reported, newest first, including grants, exercises and derivative securities. Purchases and sales (codes P and S) are open-market trades. The reported price is as stated on the form.

What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.

DateCompanyTransactionSharesReported priceValueFiling
2025-12-11Wave Life Sciences, Inc.10% owner Purchase1,470,000$19.00$27.9mForm 4
2024-09-27Wave Life Sciences, Inc.10% owner Purchase2,791,930$8.00$22.3mForm 4
2023-12-07Wave Life Sciences, Inc.10% owner Purchase3,300,000$5.00$16.5mForm 4
2020-07-15Bicycle Therapeutics plc10% owner Sale78$19.25$1.5kForm 4
2020-07-15Bicycle Therapeutics plc10% owner Sale3,069$19.4016$59.5kForm 4
2020-07-14Bicycle Therapeutics plc10% owner Sale1,597$19.274$30.8kForm 4
2020-05-20Progyny, Inc.10% owner Sale4,000,000$25.75$103.0mForm 4
2019-10-29Progyny, Inc.10% ownerConversionSeries B Preferred Stock9,821,190$0.00$0Form 4
2019-10-29Progyny, Inc.10% ownerConversion9,821,190not reportednot reportedForm 4
2019-07-22Fulcrum Therapeutics, Inc.10% ownerConversionSeries B Preferred Stock12,500,000$0.00$0Form 4
2019-07-22Fulcrum Therapeutics, Inc.10% ownerConversion1,785,714not reportednot reportedForm 4
2019-05-28Bicycle Therapeutics plcDirector, 10% ownerConversionSeries B1 Preferred Shares445,323$0.00$0Form 4
2019-05-28Bicycle Therapeutics plcDirector, 10% ownerConversionSeries A Preferred Shares625,049$0.00$0Form 4
2019-05-28Bicycle Therapeutics plcDirector, 10% owner Purchase385,714$14.00$5.4mForm 4
2019-05-28Bicycle Therapeutics plcDirector, 10% ownerConversion636,366not reportednot reportedForm 4
2019-05-28Bicycle Therapeutics plcDirector, 10% ownerConversion893,195not reportednot reportedForm 4
2018-07-17Spero Therapeutics, Inc.10% owner Purchase80,000$12.50$1.0mForm 4
2017-11-06Spero Therapeutics, Inc.10% ownerConversionSeries C preferred stock3,683,045$0.00$0Form 4
2017-11-06Spero Therapeutics, Inc.10% ownerConversionSeries B preferred stock1,250,000$0.00$0Form 4
2017-11-06Spero Therapeutics, Inc.10% ownerConversionSeries A preferred stock982,906$0.00$0Form 4
2017-11-06Spero Therapeutics, Inc.10% ownerConversionJunior preferred stock1,483,784$0.00$0Form 4
2017-11-06Spero Therapeutics, Inc.10% owner Purchase428,571$14.00$6.0mForm 4
2017-11-06Spero Therapeutics, Inc.10% ownerConversion606,024not reportednot reportedForm 4
2017-11-06Spero Therapeutics, Inc.10% ownerConversion328,992not reportednot reportedForm 4
2017-11-06Spero Therapeutics, Inc.10% ownerConversion246,272not reportednot reportedForm 4
2017-11-06Spero Therapeutics, Inc.10% ownerConversion244,147not reportednot reportedForm 4
2016-10-24CRISPR Therapeutics AG10% ownerConversionSeries B Preferred Shares211,567$0.00$0Form 4
2016-10-24CRISPR Therapeutics AG10% ownerConversionSeries A-3 Preferred Shares2,942,560$0.00$0Form 4
2016-10-24CRISPR Therapeutics AG10% owner Purchase66,500$14.00$931.0kForm 4
2016-10-24CRISPR Therapeutics AG10% ownerConversion211,567not reportednot reportedForm 4
2016-10-24CRISPR Therapeutics AG10% ownerConversion2,942,560not reportednot reportedForm 4
2016-10-18CRISPR Therapeutics AG10% ownerGrant or awardStock Option30,000$0.00$0Form 4

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Nov 1, 2026, 07:07 ET. Listed shows no prices and gives no investment advice.